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Purpose: To investigate the role of tenascin-C in epithelial-mesenchymal transition (EMT) of the lens epithelium during
wound healing in mice. Tenascin-C is a component of the extracellular matrix in patients having post-operative capsular
opacification.
Methods: The crystalline lens was injured by needle puncture in tenascin-C null (KO, n=56) and wild-type (WT, n=56)
mice in a C57BL/6 background. The animals were killed at day 2, 5, or 10 post-injury. Immunohistochemistry was
employed to detect α-smooth muscle actin (αSMA), a marker of EMT, collagen type I, transforming growth factor β1
(TGFβ1), phospho-Smad2, phospho-adducin, and phospho-myosin light chain 9 (MLC9). The expression levels of
phospho-adducin and phospho-MLC9 were used as markers for the activation of protein kinase C and Rho kinase,
respectively.
Results: The expression of tenascin-C was upregulated in WT lens epithelial cells adjacent to the capsular break at day
5. The results showed that injury-induced EMT of the mouse lens epithelium, as evaluated by histology and the expression
patterns of αSMA and fibronectin, was attenuated in the absence of tenascin-C. Upregulation of TGFβ1 expression in the
epithelium was also inhibited, and loss of tenascin-C attenuated the phosphorylation of Smad2 and adducin in epithelial
cells adjacent to the capsular break. The expression of phospho-adducin was suppressed, while the expression level of
phospho-MLC9 was unchanged, in the healing epithelium in the absence of tenascin C.
Conclusions: Tenascin-C is required for injury-induced EMT in the mouse lens epithelium. The mechanism behind this
might involve impaired activation of cytoplasmic signaling cascades; i.e., TGFβ/Smad and protein kinase C-adducing
signaling, in the absence of tenascin-C.
Upon injury to the anterior capsule, the lens epithelial
cells  transdifferentiate  into  fibroblastic  cells,  which  are
capable  of  expressing  fibrous  extracellular  matrix  (ECM)
components during the healing process. This process is called
the epithelial-mesenchymal transition (EMT) [1,2]. However,
EMT often leads to the formation of scar tissue (post-operative
capsular opacification, PCO), which impairs post-operative
vision,  rather  than  the  regeneration  of  normal  lens  tissue
[3-7]. The expression of α-smooth muscle actin (αSMA) and
fibrous collagen is characteristic of myofibroblasts [8-10], and
these molecules are also established markers of EMT in lens
epithelial cells [3,4]. It has been well established that EMT of
in vivo lens epithelial cells and other cell types is induced by
transforming growth factor β (TGFβ) [2,7,11-18]. Although
various signaling cascades are involved in gene expression
regulation in EMT, the Smad2/3 and Rho kinase cascades,
both of which can be activated by TGFβ, are the two major
pathways.
Correspondence  to:  Sai-ichi  Tanaka,  M.D.,  Department  of
Ophthalmology, Wakayama Medical University, 811-1 Kimiidera,
Wakayama,  641-0012,  Japan;  Phone:  81-73-447-2300;  FAX:
81-73-448-1991; email: s-tanaka@wakayama-med.ac.jp
Various ECM molecules; i.e., laminin, collagen types I
and  III,  lumican,  osteopontin,  fibronectin,  etc.,  are
upregulated  in  lens  epithelial  cells  post-EMT  [8-10].  In
addition, the TGFβ signaling EMT involved in various cell
types is further modulated by ECM molecules expressed by
the cells themselves; i.e., fibronectin, lumican, collagen types
I and III, fibulin-5, and osteopontin [19-30]. Integrin-derived
signaling activated by matrix binding is also required for
EMT.
Tenascin-C is a disulfide-bonded hexamer of a matrix
component composed of subunits with molecular weights in
the range of 120–300 kDa [31,32]. Tenascin-C expression is
also upregulated in post-EMT lens epithelial cells in human
PCO [33], suggesting a role for tenascin-C in EMT. A similar
mechanism  has  been  postulated  for  the  progression/
acquisition of invasive characteristics by cancer cells, which
is considered to be a type of EMT; tenascin-C is abundantly
detected in the invasive margin of cancers, where the cancer
cells express an intermediate filament, vimentin, a marker of
EMT in neoplastic cells [34,35]. Moreover, it was reported
that the absence of tenascin-C suppresses the development of
experimental  liver  fibrosis  in  mice  [36].  The  mechanism
behind  this  involved  the  attenuation  of  fibroblast-
Molecular Vision 2010; 16:1194-1205 <http://www.molvis.org/molvis/v16/a133>
Received 16 November 2009 | Accepted 24 June 2010 | Published 1 July 2010
© 2010 Molecular Vision
1194myofibroblast  conversion  and  presumably  EMT  of
hepatocytes associated with reduced expression of fibrogenic
cytokines. This finding prompted us to hypothesize that loss
of this molecule also attenuates EMT in vivo; i.e., in the lens
epithelium  post-injury,  because  both  EMT  and  fibroblast-
myofibroblast conversion produce myofibroblasts, the key
player in tissue fibrosis formation. To address this question in
the present study, we took advantage of the availability of
tenascin-C  null  (KO)  mice  [37],  and  showed  that  injury-
induced EMT of the mouse lens epithelium was perturbed in
KO mice.
METHODS
Our experiments were approved by the DNA Recombination
Experiment  Committee  and  the  Animal  Care  and  Use
Committee of Wakayama Medical University, Wakayama,
Japan and were conducted in accordance with the Association
for Research in Vision and Ophthalmology Statement for the
Use of Animals in Ophthalmic and Vision Research.
Lens injury in mouse eyes: Lens injury was performed as
previously reported [4,17,31]. We employed the protocol for
mouse  lens  capsular  injury  approved  by  National  Cancer
Institute/National  Institutes  of  Health,  Bethesda,  MD
(Laboratory of Cell Regulation and Carcinogenesis). KO mice
with a C57Bl/6 background (n=56) and wild-type (+/+, WT,
n=56)  mice  were  generally  anesthetized  with  an
intraperitoneal (i.p.) injection of pentobarbital sodium (70 mg/
kg  bodyweight)  and  were  then  topically  administered
oxybuprocaine  eye  drops  [4,17,26].  Our  preliminary
investigation showed that the incidence of EMT in the lens
epithelium  post-injury  was  similar  between  the  WT  and
heterozygous mice (data not shown). A small corneal incision
was made in the central anterior capsule of one eye (right) with
a 26 G hypodermic needle through a corneal incision after
topical application of mydriatics, as previously reported [4,
17,26]. In brief, the central anterior lens capsule was pierced
once with the blade of the 26 gauge needle. The depth of
puncture  from  the  corneal  surface  was  approximately
300 μm, which was about one quarter of the length of the
needle blade. The animals that accidentally received a deeper
lens  injury  were  not  included  in  the  experiment.  After
instillation of ofloxacin ointment, the mice were allowed to
heal for 2, 5, or 10 days. The number of eye samples were
20/20, 21/21/, and 21/21 for the WT/KO mice at 2, 5, and 10
days,  respectively.  Most  of  the  enucleated  globes  (16/16,
17/17, and 17/17 for the WT/KO mice at 2, 5, and 10 days,
respectively) were fixed and embedded in paraffin, and the
rest were embedded in optimal cutting temperature (OCT)
compound for cryosectioning, as previously reported [4,17,
26].
Histology  and  immunohistochemistry:  Deparaffinized
sections  and  fixed  cultured  cells  were  processed  for
immunohistochemistry as previously reported [4,17,26]. The
antibodies used were anti-tenascin C antibody (1:100 in PBS;
Chemicon, Temecura, CA), mouse monoclonal anti-αSMA
antibody  (1:100  in  PBS;  Neomarker,  Fremont,  CA),  goat
polyclonal anti-fibronectin antibody (1:100 in PBS; Southern
Biotechnology,  Birmingham,  AL),  goat-polyclonal  anti-
phospho-Smad2 antibody (1:100 in PBS; Chemicon), goat
polyclonal anti-phospho-adducin (Ser 726) antibody (1:200
in PBS; Santa Cruz Biotechnology, Santa Cruz, CA), goat
polyclonal anti-TGFβ1 antibody (1:200 in PBS; Santa Cruz
Biotechnology), goat polyclonal anti-TGFβ2 antibody (1:200
in PBS; Santa Cruz Biotechnology), goat polyclonal anti-
TGFβ receptor type I (TGFβ-RI) antibody (1: 200 in PBS,
Santa Cruz Biotechnology), and goat polyclonal anti-TGFβ
receptor type II (TGFβ-RII) antibody (1:200 in PBS; Santa
Cruz Biotechnology). After being allowed to react with the
secondary  peroxidase-conjugated  antibody  and  washed  in
PBS,  the  antibody  complex  was  visualized  using  3,3′-
diaminobenzidine.  Immunostaining  for  TGFβ1  was
performed  as  previously  reported  [17].  Activation  of  the
protein kinase C cascade was assayed by immuno-detection
of  phospho-adducin  (Ser  726).  Activation  of  Rho  kinase
signaling was evaluated by immuno-detection of phospho
(Thr 18/Ser 19)-myosin light chain 9 in cryosections (7 μm in
thickness) fixed in cold acetone. After nuclear counterstaining
with methyl green, the specimens were observed under regular
light microscopy.
RESULTS
Immunohistochemistry  for  tenascin-C:  As  tenascin-C
expression is reportedly upregulated in human lens epithelial
cells during PCO, we first examined whether mouse lens
epithelial  cells  express  tenascin-C  post-injury  using
immunohistochemistry. No immunoreactivity for tenascin-C
was detected in the uninjured lens epithelia or the injured lens
epithelia at day 2 post-injury, but tenasin-C immunoreactivity
was observed in the lens epithelium cells adjacent to the break
in the anterior capsule at day 5 post-injury (Figure 1). The KO
lens epithelium did not expressed tenascin-C post –injury
(data not shown).
Histology of injured mouse lenses: We examined the effects
of endogenous tenascin-C on injury-induced EMT of the lens
epithelium  using  HE  staining  .  The  histology  of  the  HE-
stained tissues showed a marked alteration in the morphology
of the cells at the injury site in the WT mice (Figure 2). The
lens epithelial cells of the uninjured lens and those at the
capsular  break  at  day  2  post-injury  maintained  a  non-
elongated morphology in both the WT (Figure 2A and insert)
and KO mice (Figure 2B and insert). At day 5 (Figure 2C and
insert) and 10 (Figure 2E and insert), the WT cells exhibited
an elongated, fibroblast-like morphology in all the specimens
examined, suggesting that EMT had occurred. At these time
points, the lens capsule adjacent to the break was folded,
presumably by contraction of the myofibroblasts in the WT
tissues, while it did not appear to be folded or contracted in
the KO tissues. On the other hand, the KO lens epithelial cells
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1195Figure  1.  Expression  of  tenascin-C
protein  in  the  injured  mouse  lens
epithelium. Neither the epithelium of an
uninjured lens (A) nor that of an injured
lens at day 2 post-injury (B, asterisk)
was  labeled  for  tenascin-C.  C:
Immunoreactivity  for  tenascin  C  was
observed  in  the  lens  epithelium
(asterisk) adjacent to the break in the
anterior  capsule  at  day  5  post-injury.
The  arrows  indicate  the  edge  of  the
break in the anterior capsule. Bar, 10
μm.
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1196were  of  epithelial  shape,  even  at  day  5,  in  all  specimens
examined  (Figure  2D  and  insert).  Finally,  the  KO  cells
exhibited  a  fibroblastic,  elongated  morphology  at  day  10
(Figure 2F and insert).
Immunohistochemistry  for  EMT-related  components:  HE
histology suggested that loss of tenascin-C attenuated the
EMT process in the lens epithelium. Therefore, we conducted
immunodetection  of  αSMA,  fibronectin,  and  TGFβ1  to
confirm this hypothesis. Our previous papers demonstrated
the upregulation of the lens epithelium αSMA protein level at
day 5 post-injury. Both the WT and KO epithelial cells of the
uninjured lenses and those of the injured lenses from each
mouse type were negative for αSMA at day 2 (not shown).
The multi-layered fibroblast-like lens cells observed at the
capsular break in the WT mice were markedly labeled for
αSMA at day 5 (Figure 3A), whereas the epithelial-shaped
lens cells in 15 of 17 KO mice were negative for αSMA at this
time point (Figure 3B). At day 10, the majority of the cells
beneath the broken capsule were labeled with anti-αSMA
antibody both in the WT and the KO lenses (Figure 3C,D). As
Figure 2. Histology of the edge of the break in the anterior lens capsule in wild-type (WT) and tenascin-C null (KO) mice. At day 2, the lens
epithelial cells around the capsular break (arrows) exhibited an epithelial-like morphology in both the WT (A and insert; asterisk) and KO
(B and insert; asterisk) mice. At day 5, the epithelial cells had formed a multilayer at the edge of the broken capsule in both the WT (C) and
KO (D) mice. The wound indicated by the arrows was filled with cells in the WT mice (C), while that in the KO mouse lens remained open
(D). At a higher magnification, the WT cells (C, insert) showed an elongated fibroblast-like shape (asterisk), while those of the KO lens (D,
insert) exhibited an epithelial-like morphology (asterisk). At day 10, a multi-cellular layer had formed beneath the anterior capsule in both
the WT (E) and KO (F) mice. At a higher magnification, the cells in both groups (E and F; inserts) exhibited an elongated fibroblast-like
shape. Inserts of A to F show the higher magnification images of the boxed areas in A through F. AC, anterior lens capsule, Bar, 10 μm (A
through F), or 25 μm for each of the inserts.
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1197shown by HE histology, at day 5 an area of the lens capsule
adjacent  to  the  break  was  folded,  presumably  by  the
contraction of myofibroblasts in the WT tissues, while folding
or contraction was seen in the KO tissues.
Fibronectin is a major adhesive glycoprotein involved in
wound  healing.  Immunostaining  clearly  showed  that
fibronectin protein expression in the lens epithelial cells of the
injured lens was inhibited in the KO mice. At day 2, no
fibronectin was detected in the injured lens epithelia of the
WT or KO mice (not shown). At day 5, loss of tenascin-C
suppressed the upregulation of fibronectin expression in the
injured  lens  epithelium;  lens  cells  of  a  fibroblastic
morphology (that were labeled for αSMA) were labeled for
fibronectin in WT mice (Figure 4A), although the cells in the
KO mice were negative (Figure 4B). At day 10, the lens
epithelia in the injured lenses of both the WT and KO mice
were positive for fibronectin (Figure 4C,D).
Although we previously reported that the most important
type of TGFβ for the activation of Smad signaling in the
injured mouse lens epithelium is TGFβ2 derived from the
aqueous  humor  [4],  there  is  a  possibility  that  autocrine
TGFβ1  also  affects  these  cells.  The  present
immunohistochemical analysis did not detect TGFβ1 in the
uninjured lens epithelium, as previously reported (data not
shown) [17]. TGFβ1 expression (Figure 5A) was upregulated
in  the  EMT  lens  epithelium  in  the  WT  mice,  while  this
upregulation was quite minimal in the KO mice at day 2. At
day 5, the anterior lens epithelium adjacent to the capsular
break was labeled for TGFβ1 in both the WT and KO mice
(Figure 5C,D). TGFβ2 was detected in the whole the lens
epithelium of the uninjured and healing lenses in both the WT
and KO mice (data not shown). TGFβ2 was constitutively its
expressed in the lens epithelium, and its expression pattern in
the healing epithelium was not affected by the loss of TNC
(data not shown).
Regarding  the  TGFβ  receptors,  we  examined  the
expression patterns of TGFβ-RI and TGFβ-RII in the injured
lens epithelium using immunohistochemistry. Both the WT
and KO lens uninjured lens epithelia were very faintly labeled
with antibodies against TGFβ-RI and TGFβ-RII (data not
shown). At day 5 post-injury, multilayered lens epithelial cells
in the injured lenses were markedly labeled with anti-TGFβ-
RI in the WT mice, while its immunoreactivity was quite faint
in the cells from the KO mice (Figure 6A,B). At day 10, the
cells in the mutilayer beneath the anterior lens capsule were
labeled for TGFβ-RI in both the WT and KO mice (Figure
6C,D). At day 5 post-injury, the multilayered lens epithelial
cells in the injured lenses were markedly labeled with anti-
TGFβ-RII in the WT mice, while its immunoreactivity was
quite faint in the cells from the KO mice (Figure 6E,F). Even
at  day  10,  the  immunoreactivity  for  TGFβ-RII  was  more
Figure 3. Expression pattern of α-smooth muscle actin (αSMA) in lens epithelial cells of injured lenses. The multicellular layer of epithelial
cells at the edge of the broken capsule was strongly labeled with anti-αSMA antibody in a wild-type mouse at days 5 (A, asterisk) and 10
(C, asterisk). On the other hand, in a tenascin-C null (KO) mouse almost none of the epithelial cells in the multicellular layer were stained for
αSMA at day 5 (B). At day 10, the majority of the cells were labeled in the KO mouse (D, asterisk). Arrows, edges of the injured anterior
capsule. AC, anterior capsule; Bar, 10 μm.
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1198prominent in the WT cells than in the KO cells (Figure 6G,H).
TGFβ-related signaling mediators. As for the TGFβ-related
signaling cascades, we examined whether Smad2 and adducin
were phosphorylated in the epithelia examined. Adducin is a
membrane  cytoskeletal  protein  that  is  phosphorylated  in
association with the activation of multiple signaling pathways
such as the Rho kinase and protein kinase C pathways [38].
The uninjured lens epithelia of the WT and KO mice were
negative for phospho-Smad2 (Figure 7A,B). At day 2, lens
epithelial cells containing nuclei labeled for phospho-Smad2
were observed adjacent to the break in the anterior capsule in
the WT mice (Figure 7C), whereas the epithelial cells in the
KO mice were not labeled (Figure 7D). At day 5, many cells
with phospho-Smad2-positive nuclei were observed around
the capsular break in the WT mice (Figure 7E). At this time
point, the majority of the lens epithelial cells in the cell multi-
layer that had formed adjacent to the break in the KO mice
were negative for phospho-Smad2 (Figure 7F). At day 10, the
cells around the break in the anterior capsule were not labeled
for phospho-Smad2 in either the WT or KO mice (Figure
7G,H).
We  next  immunostained  phospho-adducin.38  The
uninjured lens epithelia of the WT and KO mice were negative
for  phospho-adducin  (data  not  shown).  At  day  2,  lens
epithelial cells labeled for phospho-adducin were seen in the
cytoplasm adjacent to the break in the anterior capsule in the
WT mice (Figure 8A), whereas no epithelial cells were labeled
for phosoho-adducin in the KO mice (Figure 8B). At day 5,
the majority of the lens epithelial cells in the cell multi-layer
that had formed adjacent to the break in the KO mice were
still negative for phospho-adducin (Figure 8D). At this time
point,  many  elongated  cells  contining  phospho-adducin-
positive cytoplasm were observed around the capsular break
in the WT mice (Figure 8C). At day 10, the cells around the
break in the anterior capsule were not labeled for phospho-
adducin in either the WT or KO mice (Figure 8G,H).
We then evaluated the activation of Rho kinase signaling
by  immuno-detection  of  phospho  (Thr  18/Ser  19)-myosin
light chain 9. Phosphorylated-myosin light chain 9 was faintly
detected as early as day 2 in the lens epithelial cells of the
injured lenses of both the WT and KO mice and was markedly
observed thereafter in these cells in both genotypes (Figure
9). The levels of immunoreactivity in the lens epithelial cells
were similar in both genotypes.
DISCUSSION
The  present  study  was  undertaken  to  elucidate  whether
tenascin-C plays a significant role in injury-induced EMT of
the lens epithelium using tenascin-C-deficient mice. Here, we
show that the absence of tenascin-C perturbs injury-induced
EMT in mice in vivo. The present study clearly answered this
question because the myofibroblasts in healing lens must be
derived from the cells inside the lens, e. g., the lens epithelium,
without contamination of fibroblastic cells from outside the
lens. Since HE histology strongly suggested the impairment
of injury-induced EMT in the lens epithelium, we conducted
Figure 4. Expression pattern of fibronectin in injured lenses. At days 5 (A) and 10 (C), immunoreactivity for fibronectin was detected in the
multicellular layer formed at the site of capsular injury in a wild-type mouse (B), whereas no such immunoreactivity was observed in the
multicellular layer at day 5 in an injured tenascin-C null lens, although it was readily detected at day 10 (D). Arrows, edge of the injured
anterior capsule. AC, anterior capsule; Bar, 10 μm.
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1199immunohistochemistry and detected reduced expression of
αSMA  (relative  to  that  in  the  WT  lens),  a  myofibroblast
marker, in lens cells in the KO mice at day 5 post-injury. A
similar  phenomenon  was  reported  previously;  i.e.,  that
tenascin-C is specifically expressed at the invasive fronts of
cancers,  where  neoplastic  cells  acquire  a  migratory
characteristic during EMT [34,35].
The exact mechanism behind this phenomenon remains
to be investigated. We previously reported that TGFβ/Smad
signaling is essential for the occurrence of EMT in injured
mouse lenses [4,17,26]. The present immunohistochemical
analysis showed that the activation of the Smad signal was
severely  suppressed  in  the  epithelial  cells  of  injured  KO
mouse lenses compared with that in the epithelial cells of
injured  WT  mouse  lenses.  TGFβ2,  but  not  TGFβ1,
predominates  in  the  aqueous  humor  [39-41].  We  also
previously reported that TGFβ1 expression is upregulated in
the injured lens epithelium in association with the progression
of  EMT.  On  the  other  hand,  blocking  TGFβ2,  but  not
TGFβ1, in the aqueous humor abrogates Smad signaling in
the the injured mouse lens epithelium [17], suggesting that the
upregulation of TGFβ1 expression in the epithlia upon injury
Figure 5. Expression pattern of transforming growth factor β1 (TGFβ1) in injured lenses. At days 2 (A) and 5 (C), immunoreactivity for
TGFβ1 was detected in the lens epithelial cells adjacent to the site of capsular injury in a wild-type mouse. Although no such immunoreactivity
was observed in the multicellular layer at day 2 in an injured tenascin-C null lens, it was readily detected at day 10 (D). Arrows, edge of the
injured anterior capsule. AC, anterior capsule; Bar, 10 μm.
Figure 6. Expression patterns of transforming growth factor β-receptor type I and type II in an injured lens epithelium. At day 5 post-injury,
multilayered lens epithelial cells in an injured lens were markedly labeled with anti-TGFβ-RI in a wild type (WT; A) mouse, while its
immunoreactivity was quite faint in the cells of a tenascin C null (KO; B) mouse. At day 10, the cells of the mutilayer beneath the anterior
lens capsule were labeled for TGFβ-RI in both the WT and KO mice (C, D). At day 5 post-injury, the multilayered lens epithelial cells in an
injured lens were markedly labeled with anti-TGFβ-RII in a WT mouse (E), while its immunoreactivity was quite faint in the cells of a KO
mouse (F). Even at day 10, immunoreactivity for TGFβ-RII was more prominent in the WT cells than in the KO cells (G, H); Bar, 10 μm.
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1200might not play a significant role in the activation of Smad
signaling.  Thus,  in  the  present  study,  we  examined  the
expression  of  TGFβ1  in  the  injured  lens  epithelium  as  a
marker  of  the  progression  of  EMT  and  showed  that  the
upregulation of TGFβ1 expression in the epithelial cells of the
injured lens was also attenuated in the absence of tenascin-C.
The  expression  of  TGFβ2,  as  detected  by
immunohistochemistry,  in  the  lens  epithelium  was  not
affected by the absence TNC (data not shown).
Multiple signaling cascades; i.e., the protein kinase C and
Rho kinase cascades, are reportedly required for the EMT and
the expression of fibrogenic components, but TGFβ and Smad
signaling  are  considered  to  be  essential.  Adducin  is  a
membrane-associated  actin-binding  protein  that  is
phophorylated  by  protein  kinase  C  at  its  COOH-terminal
region. Protein kinase C is also involved in cell migration by
modulating the morphology of the F-actin cytoskeleton [38,
42]. We therefore examined whether the pattern of the COOH-
terminal (Ser 726) phophorylation of adducin was altered by
the loss of tenascin C in the injured lens epithelium. Our
results showed that the phosphorylation of adducin in the
injured lens epithelium was greatly reduced in the KO mice
Figure 7. Expression patterns of phospho-Smad2 in the lens epithelia of injured lenses. Uninjured lens epithelial cells beneath the anterior
capsule were not labeled for phosph-Smad2 in either the wild-type (WT; A) or tenascin-C null (KO; B) mice. At day 2, the nuclei of some
epithelial cells were labeled for phospho-Smad2 in an injured WT lens (C, arrows). On the other hand, in a KO injured lens the nuclei of the
epithelial cells at the leading edge of the cellular multi-layer were not labeled for phospho-Smad2 (D). At day 5, many epithelial cells were
founded to contain nuclei that were positive for phospho-Smad2 in the multicellular layer at the capsular break site in a WT mouse (E, arrows),
whereas no phospho-Smad2 was detected in the majority of epithelial cells in multicellular layer in an injured KO lens (F). At day 10, the
cells around the break in the anterior capsule were not labeled for phospho-Smad2 in either the WT (G) or KO (H) mice. Dotted lines, border
between the multilayered cells and the lens cortex, AC, anterior capsule; Bar, 20 μm.
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1201compared  with  the  WT  mice,  suggesting  that  the
downregulation of protein kinase C activity in the absence of
tenascin C contributes to the attenuation of lens cell EMT in
addition to the attenuation of Smad signaling. Rho kinase is
another signal that is reportedly essential for EMT in many
cell types including the lens epithelium [43,44]. We therefore
evaluated the activation of Rho kinase signaling via immuno-
detection of phospho (Thr 18/Ser 19)-myosin light chain 9.
Phosphorylated-myosin light chain 9 was faintly detected as
early as day 2 in the lens epithelial cells of the injured lenses
of both the WT and KO mice and was markedly observed
thereafter  in  these  cells,  suggesting  that  the  absence  of
tenascin C does not affect Rho kinase activity.
We also examined the expression of TGFβ receptors in
the injured lens epithelium to understand the susceptibility of
the cells to ligands. Immunohistochemistry showed that lens
epithelial cells upregulated the expression of TGFβ-RI and
RII as early as day 5 during the healing process and the
progression of EMT in the WT mice. On the other hand, as
for  the  expression  pattern  of  αSMA,  the  upregulation  of
Figure 8. Expression patterns of phospho-adducin in the lens epithelia of injured lenses. At day 2, many lens epithelial cells were labeled for
phospho-adducin in an injured wild-type (WT) lens (A, asterisk). On the other hand, in a tenascin-C null (KO) injured lens the epithelial cells
at the leading edge were not labeled for phospho-adducin (B). At day 5, many epithelial cells were positive for phospho-adducin in the
multicellular layer at the capsular break site in a WT mouse (C, asterisk), although its immunoreactivity was weaker than that in the cells at
day 2, whereas phospho-adducin was only faintly detected in the majority of epithelial cells (star) in an injured KO lens at day 5 (D). At day
10, the cells around the break in the anterior capsule were not labeled for phospho-adducin in either WT (E) or KO (F) mice; Bar, 10 μm.
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1202TGFβ receptor expression was delayed, negative at day 5, and
then positive at day 10 in the KO mice. Nevertheless, it is still
unclear whether the delayed EMT seen in the KO mice can be
ascribed  to  the  suppression  of  the  upregulation  of  TGFβ
receptor expression in the absence of tenascin-C. There is a
possibility  that  delayed  upregulation  of  TGFβ  receptor
expression in KO mice is responsible for the impairment of
the phosphorylation of Smad2 and adducin in KO cells. On
the other hand, another possible mechanism of the impairment
of  these  signaling  transmitters  is  that  the  impairment  of
integrin-derived  signals  caused  by  the  loss  of  tenascin-C
affects TGFβ-derived signaling via signaling crosstalk.
It was reported that in the stroma of the eye cornea, injury-
induced  expression  of  fibronectin,  matrix  component
essential for tissue repair, is suppressed in the absence of
tenascin-C [45]. In addition, integrin-mediated signaling is
reportedly required for fibroblast-myofibroblast conversion
and EMT in tissue fibrosis. In the present study, reduced
expression of fibronectin was also observed in the injured lens
epithelia  of  KO  mice,  suggesting  that  impairment  of
fibronectin-integrin  signaling  is  also  involved  in  the
suppression of lens cell EMT in KO mice.
Exploring the mechanism of EMT in the lens epithelium
post-injury  is  necessary  to  aid  our  understanding  of  the
pathogenesis of capsular opacification post-cataract surgery.
We reported that anti-Smad molecules inhibit EMT in the lens
epithelium  and  suggested  their  clinical  efficacy  in  the
prevention  of  PCO  [46,47].  However,  the  present  study
together with previous reports show the important roles of the
ECM in the pathogenesis of PCO. Further study is needed to
elucidate the matrix component signaling systems that are
required for the occurrence of lens cell EMT.
ACKNOWLEDGMENTS
This study was supported by Grants from the Ministry of
Education,  Science,  Sports,  and  Culture  of  Japan
(C19592036);  Mitsui  Foundation;  Mochida  Memorial
Foundation;  Takeda  Science  Foundation;  and  Uehara
Foundation.
REFERENCES
1. Hay  ED,  Zuk  A.  Transformations  between  epithelium  and
mesenchyme:  normal,  pathological,  and  experimentally
induced.  Am  J  Kidney  Dis  1995;  26:678-90.  [PMID:
7573028]
2. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika
S, Flanders KC. Smad3 is key to TGF-β-mediated epithelial-
to-mesenchymal transition, fibrosis, tumor suppression and
metastasis.  Cytokine  Growth  Factor  Rev  2006;  17:19-27.
[PMID: 16290023]
3. Saika  S,  Kawashima  Y,  Miyamoto  T,  Tanaka  SI,  Ohmi  S,
Minamide  A,  Yamanaka  O,  Ohnishi  Y,  Ooshima  A,
Yamanaka A. Immunolocalization of prolyl 4-hydroxylase
subunits,  α-smooth  muscle  actin,  and  extracellular  matrix
components in human lens capsules with lens implants. Exp
Eye Res 1998; 66:283-94. [PMID: 9533856]
4. Saika  S,  Okada  Y,  Miyamoto  T,  Ohnishi  Y,  Ooshima  A,
McAvoy JW. Smad translocation and growth suppression in
lens epithelial cells by endogenous TGFβ2 during wound
repair. Exp Eye Res 2001; 72:679-86. [PMID: 11384156]
5. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in
the  pathogenesis  of  posterior  capsule  opacification.  Br  J
Ophthalmol 2000; 84:332-6. [PMID: 10684849]
6. Wormstone  IM.  Posterior  capsular  opacification:  a  cell
biological  perspective.  Exp  Eye  Res  2002;  74:337-47.
[PMID: 12014915]
7. Saika S. Relationship between posterior capsule opacification
and intraocular lens biocompatibility. Prog Retin Eye Res
2004; 23:283-305. [PMID: 15177204]
8. Serini G, Bochaton-Piallat M-L, Ropraz P, Geinoz A, Borsi A,
Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial
for  myofibroblastic  phenotype  induction  by  transforming
growth  factor-β1.  J  Cell  Biol  1998;  142:873-81.  [PMID:
9700173]
9. Serini G, Gabbiani G. Mechanism of myofibroblast activity and
phenotypic  modulation.  Exp  Cell  Res  1999;  250:273-83.
[PMID: 10413583]
10. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA.
Myofibroblasts and mechano-regulation of connective tissue
remodelling. Nat Rev Mol Cell Biol 2002; 3:349-63. [PMID:
11988769]
11. Saika S, Miyamoto T, Tanaka T, Ishida I, Ohnishi Y, Ooshima
A. Latent TGFβ binding protein-1 and fibrillin-1 in human
Figure 9. Expression patterns of phospho (Thr 18/Ser 19)-myosin light chain 9 in lens epithelia of injured lenses. At day 2, many lens epithelial
cells were faintly labeled for phospho-myosin light chain 9 in both an injured wild-type (WT) and a tenascin-C null (KO) injured lens epithelium
(A, B, arrows). At day 5, both the WT and KO cells were obviously immunolabeled for phospho-myosin light chain 9 (C, D, arrows). AC,
anterior epithelium; Bar, 10 μm.
Molecular Vision 2010; 16:1194-1205 <http://www.molvis.org/molvis/v16/a133> © 2010 Molecular Vision
1203capsular opacification and in cultured lens epithelial cells. Br
J Ophthalmol 2001; 85:1362-6. [PMID: 11673307]
12. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-β induced
transdifferenttiation  of  mammary  epithelial  cells  to
mesenchymal cells: involvement of type I receptors. J Cell
Biol 1994; 127:2021-36. [PMID: 7806579]
13. Srinivasan  Y,  Lovicu  FJ,  Overbeek  PA.  Lens  specific
expression of transforming growth factor β1 in transgenic
mice causes anterior subcapsular cataracts. J Clin Invest 1998;
101:625-34. [PMID: 9449696]
14. Lee EH, Joo C-K. Role of transforming growth factor-β in
transdifferentiation and fibrosis of lens epithelial cells. Invest
Ophthalmol Vis Sci 1999; 40:2025-32. [PMID: 10440257]
15. Oft  M,  Akhurst  RJ,  Balmain  A.  Metastasis  is  driven  by
sequential elevation of H-ras and Smad2 levels. Nat Cell Biol
2002; 4:487-94. [PMID: 12105419]
16. Wormstone IM, Tamiya S, Andersone I, Duncan G. TGF-β2-
induced matrix modification and cell transdifferentiation in
the human lens capsular bag. Invest Ophthalmol Vis Sci 2002;
43:2301-8. [PMID: 12091431]
17. Saika  S,  Kono-Saika  S,  Ohnishi  Y,  Sato  M,  Muragaki  Y,
Ooshima A, Flanders KC, Yoo J, Anzano M, Liu CY, Kao
WW, Roberts AB. Smad3 signaling is required for epithelial-
mesenchymal transition of lens epithelium after injury. Am J
Pathol 2004; 164:651-63. [PMID: 14742269]
18. Saika  S.  TGFβ  pathobiology  in  the  eye.  Lab  Invest  2006;
86:106-15. [PMID: 16341020]
19. Hay ED. Extracellular matrix alters epithelial differentiation.
Curr Opin Cell Biol 1989; 14:455-7.
20. Zuk A, Hay ED. Expression of β1 integrins changes during
transformation of avian lens epithelium to mesenchyme in
collagen gels. Dev Dyn 1994; 201:378-93. [PMID: 7534501]
21. Saika S, Miyamoto T, Tanaka S, Tanaka T, Ishida I, Ohnishi Y,
Ooshima A, Ishiwata T, Asano G, Chikama T, Shirai A, Liu
CY, Kao CW, Kao WW. Response of lens epithelial cells to
injury: role of lumican in epithelial-mesenchymal transition.
Invest  Ophthalmol  Vis  Sci  2003;  44:2094-102.  [PMID:
12714648]
22. Zeisberg M, Bonner G, Maeshima Y, Colorad P, Muller GA,
Strutz  F,  Kalluri  R.  Collagen  composition  and  assembly
regulates epithelial-mesenchymal transdifferentiation. Am J
Pathol 2001; 159:1313-21. [PMID: 11583959]
23. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS.
Osteopontin as a means to cope with environmental insults:
regulation  of  inflammation,  tissue  remodeling,  and  cell
survival. J Clin Invest 2001; 107:1055-61. [PMID: 11342566]
24. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell
signaling and cancer progression. Trends Cell Biol 2006;
16:79-87. [PMID: 16406521]
25. Saika  S,  Miyamoto  T,  Ishida  I,  Ohnishi  Y,  Ooshima  A.
Osteopontin: a component of matrix in capsular opacification
and subcapsular cataract. Invest Ophthalmol Vis Sci 2003;
44:1622-8. [PMID: 12657601]
26. Saika S, Shirai K, Yamanaka O, Miyazaki K, Okada Y, Kitano
A, Flanders KC, Kon S, Uede T, Kao WW, Rittling SR,
Denhardt DT, Ohnishi Y. Loss of osteopontin perturbs the
epithelial-mesenchymal transition in an injured mouse lens
epithelium. Lab Invest 2007; 87:130-8. [PMID: 17211411]
27. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML,
Frank  JA,  Brumwell  AN,  Wheeler  SE,  Kreidberg  JA,
Chapman HA. Epithelial cell alpha3beta1 integrin links beta-
catenin  and  Smad  signaling  to  promote  myofibroblast
formation  and  pulmonary  fibrosis.  J  Clin  Invest  2009;
119:213-4. [PMID: 19104148]
28. Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP.
Fibulin-5 initiates epithelial-mesenchymal transition (EMT)
and  enhances  EMT  induced  by  TGF-beta  in  mammary
epithelial  cells  via  a  MMP-dependent  mechanism.
Carcinogenesis 2008; 29:2243-51. [PMID: 18713838]
29. Giehl  K,  Menke  A.  Microenvironmental  regulation  of  E-
cadherin-mediated  adherens  junctions.  Front  Biosci  2008;
13:3975-85. [PMID: 18508491]
30. Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ.
Collagen I promotes epithelial-to-mesenchymal transition in
lung  cancer  cells  via  transforming  growth  factor-beta
signaling.  Am  J  Respir  Cell  Mol  Biol  2008;  38:95-104.
[PMID: 17673689]
31. Chiquet-Ehrismann R. Tenascins. Int J Biochem Cell Biol 2004;
36:986-90. [PMID: 15094113]
32. Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin
expression by tissue microenvironments. Biochim Biophys
Acta 2008; 1793:888-92. [PMID: 19162090]
33. de  Iongh  RU,  Wederell  E,  Lovicu  FJ,  McAvoy  JW.
Transforming  growth  factor-beta-induced  epithelial-
mesenchymal  transition  in  the  lens:  a  model  for  cataract
formation. Cells Tissues Organs 2005; 179:43-55. [PMID:
15942192]
34. Orend  G.  Potential  oncogenic  action  of  tenascin-C  in
tumorigenesis. Int J Biochem Cell Biol 2005; 37:1066-83.
[PMID: 15743679]
35. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling
in cancer. Cancer Lett 2006; 244:143-63. [PMID: 16632194]
36. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H,
Sakakura T, Imanaka-Yoshida K. Deficiency of tenascin-C
attenuates liver fibrosis in immune-mediated chronic hepatitis
in mice. J Pathol 2007; 211:86-94. [PMID: 17121418]
37. Imanaka-Yoshida  K,  Matsumoto  K,  Hara  M,  Sakakura  T,
Yoshida  T.  The  dynamic  expression  of  tenascin-C  and
tenascin-X  during  early  heart  development  in  the  mouse.
Differentiation 2003; 71:291-8. [PMID: 12823230]
38. Liu PY, Liao JK. A method for measuring Rho kinase activity
in  tissues  and  cells.  Methods  Enzymol  2008;  439:181-9.
[PMID: 18374165]
39. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming
growth factor-beta in human aqueous humor. Curr Eye Res
1990; 9:963-9. [PMID: 2276273]
40. Cousins  SW,  McCabe  MM,  Danielpour  D,  Streilein  JW.
Identification  of  transforming  growth  factor-beta  as  an
immunosuppressive  factor  in  aqueous  humor.  Invest
Ophthalmol Vis Sci 1991; 32:2201-11. [PMID: 2071334]
41. Saika  S,  Liu  CY,  Azhar  M,  Sanford  LP,  Doetschman  T,
Gendron  RL,  Kao  CW,  Kao  WW.  TGFβ2  in  corneal
morphogenesis during mouse embryonic development. Dev
Biol 2001; 240:419-32. [PMID: 11784073]
42. Larsson C. Protein kinase C and the regulation of the actin
cytoskeleton.  Cell  Signal  2006;  18:276-84.  [PMID:
16109477]
43. Cho HJ, Yoo J. Rho activation is required for transforming
growth  factor-beta-induced  epithelial-mesenchymal
Molecular Vision 2010; 16:1194-1205 <http://www.molvis.org/molvis/v16/a133> © 2010 Molecular Vision
1204transition  in  lens  epithelial  cells.  Cell  Biol  Int  2007;
31:1225-30. [PMID: 17537651]
44. Berndt JD, Clay MR, Langenberg T, Halloran MC. Rho-kinase
and  myosin  II  affect  dynamic  neural  crest  cell  behaviors
during epithelial to mesenchymal transition in vivo. Dev Biol
2008; 324:236-44. [PMID: 18926812]
45. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M.
Corneal wound healing in tenascin knockout mouse. Invest
Ophthalmol Vis Sci 1999; 40:1071-80. [PMID: 10235540]
46. Saika S, Ikeda K, Yamanaka O, Sato M, Muragaki Y, Ohnishi
Y,  Ooshima  A,  Nakajima  Y,  Namikawa  K,  Kiyama  H,
Flanders KC, Roberts AB. Transient adenoviral gene transfer
of Smad7 prevents injury-induced epithelial-mesenchymal
transition  of  lens  epithelium  in  mice.  Lab  Invest  2004;
84:1259-70. [PMID: 15258599]
47. Saika  S,  Ikeda  K,  Yamanaka  O,  Flanders  KC,  Ohnishi  Y,
Nakajima  Y,  Muragaki  Y,  Ooshima  A.  Adenoviral  gene
transfer  of  BMP-7,  Id2,  or  Id3  suppresses  injury-induced
epithelial-to-mesenchymal  transition  of  lens  epithelium  in
mice. Am J Physiol Cell Physiol 2006; 290:C282-9. [PMID:
16120655]
Molecular Vision 2010; 16:1194-1205 <http://www.molvis.org/molvis/v16/a133> © 2010 Molecular Vision
The print version of this article was created on 27 June 2010. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1205